medicaid approved glp 1 Navigating Changes to GLP-1 Medication Coverage More state Medicaid programs may

Both in vivo and in vitro studies provide substantial evidence of the neuroprotective benefits of GLP-1RAs through the modulation of inflammation, mitochondrial function, ROS, tau hyperphosphorylation, and anti-apoptotic pathways

ViiV backed the supplemental application with data from the DANCE study, which evaluated Dovato in treatment-naive adolescents, along with evidence from well-controlled studies in adults

In the companys supplemental NDA, Neurocrine included data from the Phase III KINECT-HD trial and the ongoing KINECT-HD2 open-label study to establish the safety and efficacy of Ingrezza in the proposed indication

Since semaglutides patent expired in India in March 2026, generic versions have cut monthly costs by roughly 80%, making these GLP-1 medications far more accessible for Indias 100+ million people with diabetes and 250 million people who are overweight or obese

Ozempic and Mounjaro are approved for the treatment of Type 2 diabetes, while Wegovy and Zepbound are approved for weight management in adults with obesity or who are overweight

Defining phenotypic causes of obstructive sleep apnea